Crossmark

An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease

Crossref DOI link: https://doi.org/10.1038/s41398-024-03021-8

Published Online: 2024-07-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Syk, Mikaela https://orcid.org/0000-0001-9098-9833
Tornvind, Emma

Gallwitz, Maike https://orcid.org/0000-0001-9030-5470
Fällmar, David

Amandusson, Åsa

Rothkegel, Holger https://orcid.org/0000-0002-3890-8896
Danfors, Torsten

Thulin, Måns

Rasmusson, Annica J. https://orcid.org/0000-0002-7228-7755
Cervenka, Simon https://orcid.org/0000-0001-8103-6977
Pollak, Thomas A. https://orcid.org/0000-0002-6171-0810
Endres, Dominique https://orcid.org/0000-0001-7322-1195
van Elst, Ludger Tebartz https://orcid.org/0000-0002-2274-5447
Bodén, Robert https://orcid.org/0000-0002-2198-8842
Nilsson, Björn M.

Nordmark, Gunnel https://orcid.org/0000-0002-3829-7431
Burman, Joachim

Cunningham, Janet L. https://orcid.org/0000-0001-7876-7779
License Information

Text and Data Mining valid from 2024-07-24

Version of Record valid from 2024-07-24
More Information

Article History

Received: 25 October 2023

Revised: 27 June 2024

Accepted: 10 July 2024

First Online: 24 July 2024

Competing interests

: JLC has received lecturing fees from Otsuka Pharma Scandinavia, Janssen-Cilag AB and H. Lundbeck AB.

Document is current

Any future updates will be listed below